Matthew W Miller Selected Research

Matthew W Miller Research Topics

Disease

6	Aneurysm (Aneurysms) 10/2017 - 04/2012
5	Hypertension (High Blood Pressure) 02/2015 - 12/2004
5	Heart Failure 07/2012 - 05/2002
3	Patent Ductus Arteriosus 11/2017 - 09/2013
3	Intracranial Aneurysm (Cerebral Aneurysm) 10/2017 - 04/2012
3	Inflammation (Inflammations) 10/2017 - 09/2008
3	Heart Diseases (Heart Disease) 06/2017 - 07/2012
3	Body Weight (Weight, Body) 07/2006 - 05/2002
2	Cardiomyopathies (Cardiomyopathy) 01/2019 - 05/2002
2	Wounds and Injuries (Trauma) 01/2016 - 01/2015
2	Type 2 Diabetes Mellitus (MODY) 02/2015 - 03/2010
2	Ototoxicity 09/2014 - 01/2009
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2014 - 06/2013
2	Chylothorax 11/2008 - 05/2004
1	Surgical Wound Infection 10/2018
1	Rupture 10/2017
1	Infections 01/2016
1	Meniere Disease (Menieres Disease) 09/2014
1	Vertigo (Positional Vertigo) 09/2014
1	Hyperoxia 01/2014
1	Heart Arrest (Cardiac Arrest) 12/2013
1	Dyslipidemias (Dyslipidemia) 06/2013
1	Obesity 06/2013
1	Nephrogenic Fibrosing Dermopathy 11/2012
1	Hypotension (Low Blood Pressure) 07/2012
1	Heart Valve Diseases (Valvular Heart Disease) 03/2012
1	Hyperplasia 06/2011
1	Atherosclerosis 06/2011
1	Hyperglycemia 03/2010
1	Vascular Remodeling 12/2009
1	Head and Neck Neoplasms (Head and Neck Cancer) 01/2009
1	Sensorineural Hearing Loss 01/2009
1	Ischemia 09/2008
1	Myocardial Ischemia (Ischemic Heart Diseases) 09/2008
1	Hypoxia (Hypoxemia) 09/2008
1	Thrombocytopenia (Thrombopenia) 06/2008
1	Aortic Coarctation 04/2008
1	Bradycardia 07/2006
1	Atrial Fibrillation 07/2006
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 03/2006
1	Thrombosis (Thrombus) 11/2004

Drug/Important Bio-Agent (IBA)

6	Smart MaterialsIBA 11/2017 - 04/2012
3	PlatinumIBA 10/2017 - 01/2009
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2013 - 12/2004
2	GadoliniumIBA 01/2019 - 11/2012
2	nitinolIBA 11/2017 - 11/2008
2	Polyurethanes (Polyurethane)IBA 10/2017 - 05/2014
2	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 02/2015 - 06/2013
2	pimobendanIBA 07/2012 - 03/2006
2	Carvedilol (Coreg)FDA LinkGeneric 03/2012 - 03/2006
1	MetalsIBA 10/2017
1	AlloysIBA 10/2017
1	Biomarkers (Surrogate Marker)IBA 06/2017
1	Biological ProductsIBA 06/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	saxagliptin FDA Link 02/2015
1	SirtuinsIBA 02/2015
1	Gentamicins (Gentamicin)FDA LinkGeneric 09/2014
1	SteroidsIBA 09/2014
1	Troponin IIBA 06/2014
1	polyurethane foamIBA 05/2014
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 04/2014
1	dioxotechnetiumIBA 01/2014
1	beta-apocarotenoid-14',13'-dioxygenase (ADO)IBA 09/2013
1	Brain Natriuretic Peptide (Natrecor)FDA Link 09/2013
1	pro-brain natriuretic peptide (1-76)IBA 09/2013
1	gadobutrolIBA 11/2012
1	gadoterate meglumineIBA 11/2012
1	Contrast MediaIBA 11/2012
1	Clozapine (Clozaril)FDA LinkGeneric 03/2010
1	Glucose (Dextrose)FDA LinkGeneric 03/2010
1	Olanzapine (Zyprexa)FDA Link 03/2010
1	Antipsychotic Agents (Antipsychotics)IBA 03/2010
1	Transforming Growth Factor beta (TGF-beta)IBA 12/2009
1	Cisplatin (Platino)FDA LinkGeneric 01/2009
1	Peptides (Polypeptides)IBA 09/2008
1	rusalatide acetate (Chrysalin)IBA 09/2008
1	Heparin (Liquaemin)FDA LinkGeneric 06/2008
1	Contractile ProteinsIBA 04/2008
1	Proteins (Proteins, Gene)FDA Link 04/2008
1	CollagenIBA 04/2008
1	Amiodarone (Amiodarona)FDA LinkGeneric 07/2006
1	Prescription DrugsIBA 07/2006
1	EnzymesIBA 07/2006
1	SilverIBA 03/2006
1	Arginine (L-Arginine)FDA Link 12/2004
1	ArginaseIBA 12/2004
1	FibrinIBA 11/2004

Therapy/Procedure

4	Therapeutics 10/2016 - 03/2006
2	Ambulatory Surgical Procedures (Outpatient Surgery) 10/2018 - 01/2016
2	Oral Administration 07/2012 - 03/2006
2	Catheters 04/2012 - 11/2008
1	Retreatment 10/2017
1	Punctures 01/2015
1	Resuscitation 12/2013
1	Stents 06/2011
1	Combined Modality Therapy 01/2009
1	Myocardial Revascularization 09/2008
1	Cardiopulmonary Bypass (Heart-Lung Bypass) 06/2008
1	Pericardiectomy 05/2004